Add To Watchlist
Share URL
Bruker Corporation
BRKR: NasdaqGSLowest reading is at 26 out of 100. All scores are out of 100.
In Short
About The Company
CEO
Dr. Frank H. Laukien Ph.D.
Market Cap
8.35 Billion USD
Sector
Healthcare
Website
https://www.bruker.comLast Update
14/10/2026, 13:00:19
Description
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions.
Read More
Strongest readings
- ✔Debt is low at 0.75 times equity
- ✔Share count has been falling at 0.21% per year
Weakest readings
- ✘Revenue is growing at 13.56% per year while free cashflow is falling
- ✘Returns on capital have declined over five years (9.48% lower)
- ✘Earnings are negative at -0.15 per share
- ✘The current price sits above estimated fair value (margin of safety -71.96%)
Key Figures
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
Price / earnings (TTM) | N/A | 19.60x | ||
| ✘ | Margin of safety (DCF) | -71.96% | 17.95% | |
| ✔ | Revenue growth (5y average) | 13.56% | 10.97% | |
| ✘ | Dividend yield (TTM) | 0.26% | 1.85% | |
| ✔ | Share count, per year | -0.21% | 0.00% | |
| ✘ | Return on capital employed | 1.66% | 10.00% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Valuation
29 / 100Priced above the market on most measures.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
Price / earnings | N/A | 19.60x | ||
| ✘ | Free cashflow yield | 1.10% | 4.70% | |
| Price / earnings growth | N/A | 1.50x | ||
| Price / book | 3.57x | — | ||
| ✘ | Margin of safety | -71.96% | 17.95% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✘Estimated intrinsic value of 15.75 USD is below the current price of 54.80 USD
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Estimated Fair Value: 27.4 USD ✘
Current Price: 56.2 USD
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated fair value for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel for the impact this has on longterm investment returns and find a margin of safety you are comfortable with.
Growth
50 / 100Growing faster than the market on most measures.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✔ | Revenue growth | 13.56% | 10.97% | |
| ✔ | Earnings growth | 27.64% | 14.48% | |
| ✘ | Cashflow growth | -23.74% | 12.35% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✘Revenue growth has slowed this year (1.65% against a five year average of 13.56%)
- ✔Free cashflow growth has improved this year
- ✘Revenue is growing at 13.56% per year while free cashflow is falling at 23.74% per year
Health
34 / 100Balance sheet is stretched on several measures.
Measured on Leverage and capital, Funding and liquidity, Earnings quality.
| Status | Metric | Value | Reading | Threshold |
|---|---|---|---|---|
| ✘ | Altman-Z score | 2.68 | 3.00 | |
| ✘ | Piotroski score | 4.00 | 5.00 | |
| ✔ | Debt / equity | 0.75x | 0.80x | |
| ✔ | Current ratio | 1.73x | 1.00x | |
| ✘ | Interest coverage | 1.36x | 2.50x | |
| ✘ | Free cashflow / debt | 0.02x | 0.15x | |
| ✔ | Debt / capital | 0.43x | 1.00x |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Dividend
32 / 100Cover is thin on at least one measure.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✘ | Dividend yield | 0.26% | 1.85% | |
| ✘ | Dividend growth | -24.50% | 0.00% | |
| ✔ | Payout ratio (earnings) | -31.74% | 40.00% | |
| ✔ | Payout ratio (cashflow) | 24.07% | 65.00% | |
| ✘ | Worst year, last 5 years | -25.90% | -2.00% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✘Dividend growth has been slowing recently
- ✘The dividend was cut within the last five years (worst year -25.90% per share)
- ✘Financial health puts the dividend at risk (health score 34 out of 100)
Management
26 / 100Returns on capital are below the market.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✘ | Return on equity | -0.35% | 15.00% | |
| ✘ | Return on capital employed | 1.66% | 10.00% | |
| Return on assets | -0.14% | — | ||
| Free cashflow return on capital | 0.87% | — | ||
| ✘ | Return on capital, 5y change | -9.48% | 0.00% | |
| ✔ | Share count, per year | -0.21% | 0.00% | |
| ✘ | Share count, recent | 0.37% | 0.00% | |
| ✘ | Realized buyback return | -87.19% | 0.00% | |
| ✔ | Goodwill erosion / equity | 0.00% | 2.00% | |
| Price volatility, 5 year | 44.47% | — |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✘Shares were repurchased while the value score was only 29 out of 100
Analysts
not enough data| Status | Metric | Value | Reading | Neutral |
|---|---|---|---|---|
| Analyst opinion score | N/A | 50 |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Financial History
Annual figures across the full reporting history we hold.
Market Peers
BRKR
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
See 35+ Years Annual ReportsOther Information
Company Name
Bruker Corporation
Currency
USD
Beta
1.262
Vol Avg
2240268
Ceo
Dr. Frank H. Laukien Ph.D.
Cik
0001109354
Cusip
Exchange
NasdaqGS
Full Time Employees
11085
Industry
Medical Devices
Sector
Healthcare
Ipo Date
Address
40 Manning Road
City
Billerica
State
MA
Country
United States
Zip
01821
Phone
978 663 3660
Analysis Last Updated
14/10/2026, 13:00:19
Financial data compiled from SEC EDGAR filings and Yahoo Finance.